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The epigenetic control of neuronal gene expression patterns has emerged as an underlying regulatory
mechanism for neuronal function, identity, and plasticity, in which short- to long-lasting adaptation is
required to dynamically respond and process external stimuli. To achieve a comprehensive understanding
of the physiology and pathology of the brain, it becomes essential to understand the mechanisms that regu-
late the epigenome and transcriptome in neurons. Here, we review recent advances in the study of regulated
neuronal gene expression, which are dramatically expanding as a result of the development of new and
powerful contemporary methodologies, based on next-generation sequencing. This flood of new information
has already transformed our understanding of many biological processes and is now driving discoveries
elucidating the molecular mechanisms of brain function in cognition, behavior, and disease and may also
inform the study of neuronal identity, diversity, and neuronal reprogramming.Introduction
Epigenetics is a fascinating and rapidly growing field of biology
that investigates stable and heritable, but yet dynamic and
reversible, changes in chromatin modifications that have a direct
impact on regulation of transcription. Epigenetic mechanisms
assure precise transcriptional response to intrinsic and extrinsic
signals and enable the storage of regulatory information in the
genome even after signals have subsided. Epigenetic modifica-
tions have already been proven to be a core mechanism of many
neuronal processes, from the establishment of neuronal identity
to individual adaptation throughout life, in a vast diversity of
mental disorders.
The epigenome (the pattern of epigenetic modifications in the
genome) is the result of a complex interplay between enzymes
that modify DNA and histones, proteins that can recognize these
modifications, sequence-specific and nonspecific DNA binding
factors, scaffold proteins, noncoding RNAs (ncRNAs), the chro-
matin structure, and the organization of the genome in the
nuclear space. The epigenome plays an essential role in the
regulatory mechanisms that define the transcriptome (the profile
of all the transcripts expressed in a cell). Hence, the analysis of
the epigenome and transcriptome can be indicative of what
defines a cell type, its physiological state, and pathological stage
in a disease.
There are two main categories of epigenetic modifications or
‘‘marks’’: DNA methylation and histone posttranslational modifi-
cations. The precise spatial and temporal deposition and
removal of these marks is crucial to dictate the epigenomic state
of a cell, and it is achieved by the combinatorial action of different
classes of histone- andDNA-modifying enzymes. These proteins
can be classified as ‘‘readers,’’ ‘‘writers,’’ or ‘‘erasers’’ based on
their ability to recognize, add, or remove epigenetic modifica-606 Neuron 77, February 20, 2013 ª2013 Elsevier Inc.tions, respectively. Distinct epigenetic marks, in turn, can recruit
multiprotein complexes harboring different enzymatic activities
and thus amplifying the combinatorial potential of epigenetic
marks. Finally, transcription factors orchestrate the expression
of distinct sets of genes by recognizing sequence-specificmotifs
in the genome and recruiting the necessary machinery to initiate
and maintain the transcriptional response.
In the past few years, striking advances in next-generation
sequencing technologies based on deep sequencing have revo-
lutionized our understanding of epigenetic regulation of tran-
scription, shifting our focus from the classical single-locus
experimental approach to studying epigenetic events on
a genome-wide scale. Deep sequencing outputs provide rela-
tively short DNA reads (50–400 bp) (Kircher and Kelso, 2010),
which render them especially amenable for assays dedicated
to the study of regulation of gene expression. It is beyond the
scope of this Review to describe all possible applications. A
schematic overview of these approaches is shown in Figure 1
and a brief description of them can be found in Table 1. In this
Review, we attempt to highlight the way in which recent
advances in technologies that survey the epigenome and tran-
scriptome are expanding our understanding of the role of
epigenetic processes in gene regulation in neuronal as well as
in nonneuronal systems, and we will discuss the relevance of
these findings for elucidating brain function and disease.
Redefining the Organization of the Genome and Control
of Transcription in Neural Function
The combination of deep sequencing with molecular biology
techniques provides for the first time the means to study not
just expression but also regulation of transcription at the
whole-genomic level. In particular, the profiling of histone marks
Figure 1. A High Diversity of Next-Generation or Deep Sequencing Approaches Is Currently Available for Profiling Genomes, Epigenomes,
Methylomes, and Transcriptomes
A plethora of deep sequencing approaches are now available, ranging from approaches to map the primary sequence of DNA (whole-genome-seq and exome-
seq), map DNA methylation marks (meDIP-seq, 5-hmC-seq, and many others), profile chromatin structure (MNase-seq, DNase-seq, and FAIRE-seq), profile all
the different stages of the transcriptome (GRO-seq, RNA-seq, and ribo-seq), profile transcription factors, cofactors, and histone marks (ChIP-seq), profile RNA
interactions to the genome or the transcriptome (ChIRP-seq andCLIP-seq and variants), and finally profile the structure of the genome in the tridimensional space
(ChIA-PET, HiC, and several others). All these approaches are now available for the neurobiology community and are primed to revolutionize the field.
Neuron
Reviewby chromatin immunoprecipitation combined with deep
sequencing (ChIP-seq—see Table 1) has been instrumental in
the functional redefinition of the genome, including a more
comprehensive annotation of gene bodies, promoters, insula-
tors, and enhancer regions (Barski et al., 2007; Heintzman
et al., 2007, 2009; Shen et al., 2012; Wang et al., 2008). Most
recently, a slew of publications from The Encyclopedia of DNA
Elements (ENCODE) Project (http://www.nature.com/encode)
provides a broad and detailed analysis of structures and func-
tions of genomic elements (Dunham et al., 2012). For example,
it hasbeencalculated that 56%of thegenomeconsists of regions
highly enriched in epigenetically modified histones, although this
number may easily increase with the discovery and mapping of
new histone marks (Tan et al., 2011). This finding implies that
a large proportion of what was once called ‘‘junk DNA’’ might
indeed be critical for proper regulation of gene expression.
Another seminal finding coming from the application of deep
sequencing is the observation that the human genome is perva-
sively transcribed. Based on RNA sequencing (RNA-seq) anal-
ysis, the ENCODE Project currently estimates that as much as
76% of the genome is transcribed, of which only 35% lies
within genomic regions spanning protein-coding genes from
promoter to poly(A) site. Therefore, over half of the RNA
molecules that have been detected correspond to ncRNAs,
including at least 8,800 small (<200 nucleotide) and 9,600 long
(>200 nucleotide) RNAs (Djebali et al., 2012). These ncRNAsencompass classes of RNA previously described (e.g., tRNAs,
snoRNAs, and miRNAs) and also new ones of mostly as-yet-
unknown function and structure (discussed in a later section).
In this respect, the application of assays to profile RNAs that
are specifically undergoing transcription, such as the global
run-on experiment (GRO-seq), will be a valuable tool to comple-
ment the catalog of transcribed regions because it can detect
transcripts that may be too unstable to be detected by other
approaches (Core et al., 2008).
Promoters
Gene promoters can now be predicted based on the presence of
the promoter-specific histone mark H3K4me3. Additional
histone marks can be used to identify promoters in a particular
transcriptional state. For example, association of H3K4me3
with H3K9ac and H3K27ac usually correlates with promoters
of actively transcribed genes, whereas H3K4me3 associated
with H3K27me3 correlates with promoters of genes that
are primed for activation but not transcribed (‘‘poised genes’’).
In neuronal progenitors, H3K4/27me3-marked promoters
(so-called ‘‘bivalent domains’’) are associated with genes of
differentiated neurons and glia (Bernstein et al., 2006; Garrison
et al., 2007). Interestingly, independent of cell type, many
promoters harbor H3K4me3, suggesting their competence for
activation even when RNA polymerase II (RNAPII) is not actively
transcribing their corresponding genes, thus essentially defining
most genes as ‘‘poised’’ for elongation (Heintzman et al., 2007;Neuron 77, February 20, 2013 ª2013 Elsevier Inc. 607
Table 1. Examples of Assays Using Deep Sequencing Technologies
Assays profiling the
association of methylated
marks to the genome
Affinity enrichment-
based assays
MeDIP-seq (methylated DNA
immunoprecipitation), MBD-seq
Based on immunoisolation of methylated DNA fragments using an antibody that recognizes
5-methylcytosine (MeDIP-seq) or using the methyl binding domains of MBD2 or MeCP2
(MBD-seq).
Enzyme digestion-
based assays
MRE-seq (methylation-sensitive
restriction snzyme)
Based on cleavage of DNA by methylation-sensitive restriction enzymes to fragment
DNA at methylation sites before sequencing.
Bisulfite conversion-
based assays
Bis-seq (bisulfite-sequencing),
reduced representation
Bis-Seq (RRBS)
Based on the chemical conversion of unmethylated cytosine into uracil. Identifies methylated
cytosines at nucleotide resolution by comparison to untreated DNA samples or reference
genome. Bisulfate-based approaches can be combined with pre-enrichment methods,
such as array capture or bead technology, which can enrich specific DNA genomic
regions for sequencing.
OxBS-seq (oxidative bisulfite),
TAB-seq (Tet-assisted bisulfite),
and 5-hmCyt-seq (5hydroxy-
methylcytosine)
Variants of Bis-seq that specifically discriminate between 5-mC and 5-hmC
Assays profiling the
association of proteins/
histone marks/RNA
to the genome
ChIP-seq (chromatin
immunoprecipitation)
Based on enrichment of crosslinked DNA-protein complex isolated by an antibody raised
against a protein or specific histone mark of interest. The bound chromatin fraction is identified
by deep sequencing.
ChIRP-Seq (chromatin RNA
immunoprecipitation)
Variant of ChIP-seq that specifically detects association of RNA molecules to the genome.
Based on hybridization of a pool of nonoverlapping, biotinylated oligonucleotides that complement
to the sequence of the RNA of interest. The bound DNA are processed as in ChIP-seq.
Assays profiling the
association of proteins to
(RNA) the transcriptome
CLIP-seq (crosslinking and
immunoprecipitation ) and
PAR-CLIP (photoactivatable
ribonucleoside-enhanced-CLIP)
Based on UV-crosslinking to stabilize RNA and RNA binding protein interactions, followed by
immunoisolation of the RNA-protein complex using a specific antibody for the protein. Enriched
RNAs are then converted into cDNAs for sequencing (CLIP-seq). PAR-CLIP differs from
CLIP-seq in the incorporation of photoactivatable ribonucleoside analogs into the nascent
transcripts that facilitate UV-crosslinking between labeled RNAs and proteins.
Assays profiling
nucleosome positioning
MNase-seq (micrococcal nuclease),
DNase-seq (DNase I hypersensitive
sites sequencing), and FAIRE-seq
(formaldehyde-assisted isolation
of regulatory elements)
Nucleosome positioning is identified by sequencing DNA that is protected by nucleosomes
from digestion by micrococcal nucleases (MNase-seq). Alternatively, open chromatin regions
are identified and sequenced based on their hypersensitivity to DNase I digestion (DNase-seq)
or based on their solubility in the aqueous phase during phenol-chloroform extraction after
formaldehyde crosslinking (FAIRE-seq).
Assays profiling the
organization of
the genome in the
nuclear space
3C, 4C, Hi-C, and ChIA-PET Chromosome conformation capture techniques determine the physical interaction between
known genome regions (3C), unknown regions of the genome and a known bait (4C), or all
genome-wide-occurring interaction in an unbiased fashion (Hi-C). ChiA-PET involves an
immunoisolation step that allows the identification of the genomic interaction sites of
a specific protein.
Assays profiling the
transcriptome
RNA-seq and miR-seq RNA-seq profiles transcripts genome-wide in their steady-state form. Different information can be
obtained based on the specific pool of RNAs utilized, such as nuclear or cytoplasmic, or based
on specific strategies of enrichment, such as polyadenylated RNAs or small RNAs (i.e., miR-seq).
Ribo-seq (ribosome profiling) Ribo-seq profiles transcripts undergoing translation, based on sequencing ribosome-associated
RNAs. Tagging strategies of ribosomal proteins allow their affinity purification.
GRO-seq (global run-on) GRO-seq profiles nascent transcripts exclusively undergoing transcription. It is based on the
rapid isolation of nuclei and subsequent addition of biotinylated nucleotides during a short
period in which transcription is allowed to shortly proceed in vitro, effectively mapping the
position, amount, and orientation of transcriptionally engaged RNA polymerases genome-wide.
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ReviewShen et al., 2012). This type of polymerase ‘‘stalling’’ may oper-
ate in all cell types, including neurons, although the precise
mechanisms required for establishing poised promoters have
not yet been defined.
Enhancers
An innovative accomplishment of deep sequencing technologies
has been the mapping and characterization of enhancers at
genome-wide scale. Enhancers are cis-acting regulatory
elements that can enhance gene transcription from a distance
and independently of orientation. As a result of numerous
genome-wide studies, enhancers have emerged as regulatory
elements that drive cell type-specific patterns of gene expression
through binding of cell-/lineage-specific transcription factors.
Enhancers contain distinctive histone modification patterns and
histone variants compared with other cis-regulatory elements in
the genome. For example, Ren and colleagues made a seminal
contribution observing that enhancers show H3K4me1 in the
absence/low levels of H3K4me3 and are enriched in the histone
variant H2A.Z (Heintzman et al., 2007). In addition, enhancers
that harbor H3K27ac strongly correlate with cell type-specific
gene expression programs (Heintzman et al., 2009). Similarly,
enrichment of specific cofactors has been reported to be part
of a general enhancer signature. For example, the histone
acetyltransferase p300 has been found to be an effective pre-
dictor of functional enhancers in a tissue-specific manner (Visel
et al., 2009). Similarly, Greenberg and colleagues have reported
that the p300-related acetyltransferase CREB-binding protein
CBP, along with RNAPII, is recruited in an activity-dependent
manner at enhancer regions upon neuronal response to KCl
treatment (Kim et al., 2010). The authors have further shown
that enhancer elements are actively transcribed, uncovering
a novel type of long noncoding RNAs (eRNAs). Although the
functional relevance of these transcripts is still an open question,
their expression levels are intimately correlated with mRNA ex-
pression at nearby genes, and hence they might be useful to
determine functional enhancers (Kim et al., 2010; Sanyal et al.,
2012; Wang et al., 2011). Another common feature of enhancers
is their occupancy by specific combinations of cell-/lineage-
specific transcription factors. For example, a comprehensive
classification of enhancers in 17 mouse tissues, including adult
cerebellum, cortex, and embryonic E14.5 brains, revealed the
existence of neuronal subtype-specific enhancers (cortex, cere-
bellum, or E14.5 brain specific) that contain consensus DNA
binding sites for a common set of neuronal transcription factors
(e.g., Atoh1 motif in cerebellum-specific enhancers) (Shen
et al., 2012). Finally, promoters and enhancers engage in long-
range interactions, raising the question of whether this physical
association functions as an additional step to control the proper
transcriptional outcome (Sanyal et al., 2012). The mechanisms
by which enhancers contribute to regulation of transcription
are still under intense investigation; however, one hypothesis is
that these elements regulate both polymerase recruitment and
polymerase release from poised promoters and thus the rate
of transcription occurs in a cell type-, lineage-, and/or signal-
specific manner (Hah et al., 2011; Wang et al., 2011).
Transcription Factors
Studies in almost every system have shown that tissue-specific
gene expression is tightly regulated by the coordination oflineage-specific transcription factors. The application of ChIP-
seq and previously ChIP-chip technologies has been instru-
mental in uncovering the regulatory mechanism by which these
proteins act at a genome-wide level. For example, it has been
observed that only a relatively small number of binding events
of cell type-specific transcription factors occurs at promoter
regions, while the vast majority of these events occur at distal
regulatory elements including enhancers. Deep sequencing
technologies developed to profile the chromatin structure (e.g.,
DNase-seq, MNase-seq, and FAIRE-seq; Table 1) have also
confirmed at genome-wide scale that these events occur at
‘‘open’’ chromatin regions (Thurman et al., 2012).
One of the classic transcription factors that govern neuronal
identity is the neuron-restrictive silencer factor (NRSF/REST). A
large body of evidence shows how REST represses transcription
in embryonic stem cells (ESCs) or nonneuronal cells through
epigenetic processes upon binding to thousands of sites in the
genome, as detected by ChIP-seq (Johnson et al., 2007; Zheng
et al., 2009). As illustrated in Figure 2, REST/NRSF-mediated
repression in ESCs is achieved through recruitment of two
separate corepressor complexes, mSin3 and CoREST, that in
turn act as molecular scaffolds for DNA-/histone-modifying
enzymes and chromatin-remodeling factors, including histone
deacetylases (e.g., HDAC1/2), demethylases (e.g., LSD1), and
methyltransferases (e.g., G9a). These enzymes dictate a repres-
sive chromatin state for a specific subset of genes, exhibiting an
enhancement in methylated histone marks implicated in tran-
scriptional silencing (Coulson, 2005; Qureshi and Mehler,
2009). During neuronal differentiation or in neuronal cells,
REST protein level is decreased and loss of its binding from
many genomic sites is correlated with histone modifications
implicated in transcriptional activation, such as increase in acet-
ylated histone marks (Zheng et al., 2009) (Figure 2). These
studies on the mechanism of action of NRSF/REST in repressing
neuron-specific genes illustrate how transcription factors can
influence epigenetic processes by recruiting specific enzymatic
activities to target loci.
Long-Range Interactions
An additional layer of regulatory complexity in transcription
depends on long-range interactions in the genome that can be
profiled genome-wide by chromatin conformation capture (3C)
techniques integrated with deep sequencing (de Wit and de
Laat, 2012) (Table 1). The original 3C assay tests the interaction
between two known distal genomic regions. In a recent study,
circular 3C (or 4C), which is a 3C variant that detects physical
interactions between a known bait with unknown distal regions,
was employed to explore the in vivo dynamics of the three-
dimensional architecture of the Hox gene clusters, which are
expressed in a spatial and temporal manner during body axis
development in vertebrates (Noordermeer et al., 2011). Aligning
the long-range interactions detected by 4C with the repressive
H3K27me3 and active H3K4me3 histone marks, the authors
showed that inactiveHox genes (e.g., those silenced in forebrain)
are organized in a single repressive three-dimensional domain,
while active Hox genes (e.g., those transcribed in anterior or
posterior trunk tissues) are organized in three-dimensional
domains that are bimodal (H3K4/K27-me3) and transcriptionally
active (Noordermeer et al., 2011), suggesting that genomeNeuron 77, February 20, 2013 ª2013 Elsevier Inc. 609
Figure 2. Schematic Model of Regulation of
Gene Expression by REST/NRSF
In embryonic stem cells, REST/NRSF is associ-
ated with RE1-containing sequences and assures
silencing of target genes by tethering repressive
components, including HDAC1/2, LSD1, G9a,
Suv39h1, CtBP, MeCP2, and Brg1, among others.
During differentiation toward neuronal cell fate, the
REST protein level is dramatically reduced via
several mechanisms such as direct proteosomal
degradation of the protein as well as via tran-
scriptional repression and miRNA-dependent
degradation of the mRNA. Remaining low levels of
REST/NRSF protein are excluded from the
nucleus through interaction with Huntingtin.
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programs during development. Additionally, Dekker and collab-
orators mapped short- and long-range interactions in the
genome of several cell lines using chromosome conformation
capture carbon copy (5C), which detects interactions between
two targeted sets of genomic loci, such as transcription start
sites (TSSs) and distal regulatory elements. The authors found
that there is a significant correlation between gene expression,
promoter-enhancer interactions, and the presence of eRNAs,
further confirming the functional relationship among distal regu-
latory regions in the genome (Sanyal et al., 2012). Finally, the
application of HiC (Lieberman-Aiden et al., 2009), which is
a completely unbiased and open-ended 3C variant that does
not predefine which interactions will be interrogated, was used
to examine the three-dimensional architecture of the genome
in several mouse and human cell types. This analysis reported
that there are megabase-sized, highly stable, and conserved
‘‘topological domains’’ throughout the genome, which are
separated by boundary regions enriched in the zinc-finger
protein CTCF and specific histone marks that constrain hetero-
chromatin spreading, suggesting that mechanisms establishing
higher-order structures may be evolutionary conserved (Dixon
et al., 2012).
Emerging Concepts in DNA Methylation and Epigenetic
Regulatory Mechanisms of Neuronal Function
DNAmethylation is probably themost studied epigeneticmark in
the field of neurobiology (Bird, 2002; Day and Sweatt, 2010).
However, our understanding of the methylome (the genome-610 Neuron 77, February 20, 2013 ª2013 Elsevier Inc.wide distribution of DNA methylation)
has been redefined by recent studies
combining ‘‘traditional’’ techniques to
identify DNA methylation and genome-
wide-based approaches, licensed by
deep sequencing (Harris et al., 2010;
Laird, 2010). These studies have been
instrumental in redefining some long-
held views on the stability, derivative
forms, and functions of this mark. In
particular, these techniques include
assays to detect 5-methylcytosine (5-
mC) using antibodies against methylated
DNA (MeDIP-seq) or methyl bindingproteins (MBD-seq), enzyme digestion-based assays (MRE-
seq), and chemical conversion-based assays that distinguish
methylated versus nonmethylated cytosines (e.g., Bis-seq)
(Table 1).
One of the first examples of whole-genome bisulfite
sequencing (Bis-seq) compared the methylome of human
ESCs to IMR90 fibroblasts, along with their transcriptome and
ChIP-seq analysis of histone marks (Lister et al., 2009). This
study uncovered the diverse methylation landscape at nucleo-
tide resolution and identified widespread differences in the
composition and patterning of cytosine methylation between
the two cell types, as well as features such as pervasive methyl-
ation on transcribed gene bodies, depletion from 50UTRs, TSSs
and transcription termination sites, depletion of CG methylation
at protein-DNA interaction sites, and a surprising abundant
fraction of non-CG methylation. A similar approach has since
been applied to neuronal systems as well, for example, finding
that non-CG methylation is also abundant in adult mouse brain
and may play a role in imprinting (Xie et al., 2012).
Insights into the functions of methylation in the brain have
also been obtained by application of affinity enrichment-based
approaches that provide qualitative estimates of genome-wide
methylation at a much lower cost than Bis-seq, such as
MeDIP-seq (Jacinto et al., 2008) and MBD-seq (Serre et al.,
2010). In particular, MeDIP-seq has recently been successfully
employed to identify brain region-specific patterns of the
methylome in postmortem normal adult human brains, revealing
that there are distinct differences in DNA methylation patterns
between different brain regions, especially at intragenic CpG
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development and neurobiological function (Davies et al., 2012).
Furthermore, in a recent study using a combination of MeDIP-
seq and MRE-seq, it was discovered that in human brain
samples, the majority of methylated CpG islands were shown
to be in intragenic and intergenic regions associated with tran-
scribed regions, as assessed by RNA-seq, whereas less than
3% of CpG islands in 50 promoters were methylated. In addition,
tissue-specific DNA methylation regulated intragenic promoter
activity, leading to alternative transcripts expressed in a tissue-
and cell type-specific manner, from distinct brain regions, thus
supporting a role for intragenic methylation in regulating cell
context-specific alternative promoters in gene bodies (Mauna-
kea et al., 2010). These findings demonstrate that different cell
types or tissues are characterized by distinct DNA methylation
patterns and suggest that this epigenetic modification may
play a direct role in establishing cell type-specific patterns of
gene expression.
Our understanding of the role of DNAmethylation in repression
of imprinted genomic regions has also increased by the use of
deep sequencing approaches. Imprinted regions are broad
genomic domains, which are heavily methylated and transcrip-
tionally repressed. Recently, Ren and colleagues utilized Bis-
seq to identify new imprinted brain loci by comparing parents
and offspring derived from breeding two different strains of
mice (Xie et al., 2012). By generating an allelic methylation
map, they discovered 55 imprinted CpG clusters, which include
23 novel imprinted clusters, with some occurring on microRNA
genes, as well as abundant non-CpG methylation that can be
allele specific. These results may provide a basis to further
understand the mechanisms of imprinting and allele-specific
gene expression. Moreover, the authors observed that the
adjacent sequence has a strong impact in determining DNA
methylation, suggesting an evolutionarily conserved sequence
code controlling DNA methylation in the mammalian genomes.
Dynamics of DNAMethylation and the NewAppreciation
forDemethylation asRegulatoryMechanism in theBrain
Until recently, DNA methylation had been considered a perma-
nent, nonreversible epigenetic modification of DNA that could
only be lost by a passive process due to consecutive cell divi-
sions in the absence of DNA methyltransferase (Dnmt1), which
is responsible for DNA methylation maintenance. However,
DNA demethylation has garnered renewed interest since it now
appears that active DNA-demethylation can occur by different
enzymatic mechanisms including direct removal of the methyl
group of 5-mC, base excision repair (BER) through direct exci-
sion of the 5-mC, deamination of 5-mC to T followed by BER
of the T/G mismatch, nucleotide excision repair (NER), oxidative
demethylation, and radical SAM-based demethylation (Wu and
Zhang, 2010, 2011) (Figure 3B).
However, the biological implications of methylation dynamics
have been addressed, until recently, predominantly in nonneuro-
nal systems. In particular, DNA methylation levels can be
dramatically reduced in response to ligand-dependant nuclear
receptor signaling, suggesting that DNA demethylation may
play a role in regulated gene expression, particularly in response
to acute stimuli, such as upon hormone stimulation (Kim et al.,2009; Me´tivier et al., 2008). In neuronal models, recent
genome-wide efforts have shown activity-dependent changes
in DNA methylation in the brain. Song and colleagues used
a single-nucleotide MSCC sequencing-based methodology (a
variant of MRE-seq) to assay for changes in CpG methylation
after synchronous activation of hippocampal dentate granule
cells by electroconvulsive stimulation (Guo et al., 2011). The
authors found that a subset of CpG dinucleotides from the
200,000 CpGs assayed either gained or lost methylation after
activity-dependent signals. The genes associated with the
changes in CpGmethylation were related to brain-specific genes
and their expression was anticorrelated to increased methyla-
tion. Interestingly, a large proportion of the dynamically methyl-
ated CpGs were not associated with gene regions, raising the
possibility that they might be associated with either the expres-
sion of nonannotated genes, such as ncRNAs, or affecting distal
genomic regulatory elements, rather than promoters or gene
bodies directly, suggesting that neuronal activity-dependent
changes in methylation may play a role in distal regulation of
transcription, such as enhancers and/or insulators. This is sup-
ported by the observation that DNA methylation affects the level
of transcription factor binding to the genome and that changes in
DNA methylation have been directly observed at enhancer
regions (Stadler et al., 2011; Thurman et al., 2012; Wiench
et al., 2011). Schubeler and colleagues surveyed the methylome
in ESCs and neural progenitor cells (NPCs) using Bis-Seq (Sta-
dler et al., 2011). They found that whilemost CpGs in the genome
were highly methylated, as expected, a small subset (4%)
showed low to intermediate levels of methylation, in the range
of 10%–50%methylation. These areas, coined ‘‘low methylated
regions’’ (LMRs), were evolutionarily conserved and were not
found in CGIs, which were identified as regions of low CpG
methylation. These regions contained chromatin marks that are
characteristic of distal regulatory elements and function as
enhancers in experimental assays. Moreover, when ESCs were
differentiated to NPCs, new LMRs were formed adjacent to
genes important for neuronal development. Thus, LMRs may
define a subset of methylated regions that are dynamically
changed, possibly through the recruitment of DNA binding tran-
scription factors, allowing for highly localized changes in methyl-
ation during development in order to regulate specific gene
transcription programs. Taken together, these provocative
results suggest that methylation dynamics in the brain may be
more common than previously anticipated and may serve as
amechanism to control gene expression in response to neuronal
activity. However, the full spectrum of changes in methylation
has yet to be characterized, and the response to other forms
of neuronal activity needs to be explored.
5-Hydroxymethylcytosine and Other Cytosine
Modifications Emerging as New Epigenetic
Modifications in Development and Disease
5-hydroxymethylcytosine (5-hmC) is another product of the 5-
mC demethylation process and is emerging as an important
epigenetic mark that is particularly enriched in brain regions,
perhaps playing a role in development, aging, and disease
(Tan and Shi, 2012). The initial challenge for detecting 5-hmC
was that bisulfite conversion could not discriminate betweenNeuron 77, February 20, 2013 ª2013 Elsevier Inc. 611
Figure 3. Dynamics of DNA Methylation
(A) Dynamics of DNA methylation. DNA methyla-
tion changes can be brought about by diverse
signals such as neuronal activity or during devel-
opment. Active promoters are generally un-
methylated (open circles), allowing the binding of
transcription factors (TF), recruiting RNA poly-
merase (RNA Pol II), and other factors for tran-
scription to occur. Upon methylation (closed
black circles), methyl binding proteins (MBPs) are
recruited to promoters and recruit repressive
machinery such as histone deacetylases (HDACs)
and Corepressors (CoRep), which lead to reduced
transcription. In some cases, further recruitment of
other enzymes such as the H3K9HMT Suvar39h
(K9HMTs), which deposit the H3K9me3 mark on
histone tails, can lead to further repression by re-
cruiting HP1, condensation of the chromatin, and
spreading of the repressive state. Similarly, DNA
methylation changes can occur on enhancers,
which, when unmethylated (open circles), allow the
binding of transcription factors and other proteins
required for enhancer activity.
(B) DNA methylation variants. A series of enzymes
are capable of demethylating 5-methyl Cytosines
(5-mC) to an unmethylated state, with various
intermediates. TET1, a member of the Tet family of
proteins, is a 5-mC dioxygenase responsible for
catalyzing the conversion of 5-mC to 5-hydrox-
ymethylcytosine (5-hmC) and further to 5-for-
mylcytosine (5-fC) and/or 5-carboxylcytosine
(5-caC). Alternatively, 5-hmC can be deaminated
to 5-hydroxymethyluracil (5-hmU). These deriva-
tives of 5-hmC can be further converted to an un-
methylated state via various mechanisms such as
glycosylation by TDG and the base excision repair
(BER) machinery. These various modifications
highlight the newly found diversity and dynamics in
the DNA methylation landscape; however, the
precise roles of these modifications have yet to be
determined. The suggested role of these modifi-
cations is described below each of them.
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DNA with reagents that selectively modify the conversion
properties of either 5-mC or 5-hmC in the bisulfite treatment.
Several similar strategies allow the identification of 5-hmCs
after subtracting the sequencing information obtained by this
procedure compared to standard bisulfite procedure alone
(OxBS-seq, Booth et al., 2012; TAB-seq, Yu et al., 2012; and
5-hmC-seq, Szulwach et al., 2011).
Using such approaches, 5-hmCwas initially found in ESCs but
is about 10-fold more abundant in terminally differentiated cells,
such as Purkinje neurons (Kriaucionis and Heintz, 2009). Studies
using affinity-based approaches have demonstrated that 5-hmC
is enriched at promoters, enhancers, CTCF binding sites, and
gene bodies (particularly exons), suggesting a role in gene regu-
lation. In fact, in a recent study, half of all 5-hmC modification
sites observed in ESCs occurred in distal and chromatin-acces-
sible genomic sites, as mapped by ChIP-seq, DNase-Seq, and
TAB-seq (Yu et al., 2012). This work also revealed strand asym-
metry at 5-hmC sites, in contrast to 5-mC sites, and detected
high levels of 5-hmC and reciprocally low levels of 5-mC near
but not at cis-regulatory elements for transcription factors. While
it is still unclear what the significance of these new DNA modifi-
cations will be, it is clear that in some instances genes known to
be involved in brain function are tightly linked with such DNA612 Neuron 77, February 20, 2013 ª2013 Elsevier Inc.modifications. For example, it has been shown that 5-hmC levels
were inversely correlated with the dosage of MeCP2, which is
a methyl binding protein mutated in the autism spectrum
disorder Rett syndrome (Szulwach et al., 2011). In this study,
the levels of 5-hmC in Mecp2 null mice brains were shown to
be increased mainly on gene bodies and also that MeCP2 was
able to block in vitro TET-dependent conversion of 5-mC to 5-
hmC. However, at dynamically differential 5-hydroxymethylated
regions, 5-hmC was reduced in theMeCP2 null brains, suggest-
ing that the role of MeCP2 in maintaining proper 5-hmC levels
may be context dependent and that 5-hmC-mediated epigenetic
modification may be critical in neurodevelopment and disease.
This will still need to be further studied, since recent work has
shown that indeed 5-hmC is primarily bound in the brain by
MeCP2 and is associated with active transcription, but no
change in 5-hmC levels were detected in MeCP2 null neurons
(Melle´n et al., 2012).
How Do Neurons ‘‘Read’’ DNA Methylation and Interpret
Changes in Levels of DNA Methylation?
A wealth of data suggests that the ability to ‘‘read’’ DNA methyl-
ation is important for brain development and function. However,
what are the mechanisms that are required to read this mark
and in what way, and what are the consequences of not reading
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demonstrated DNA methylation was transcriptional repression,
especially when affecting promoter regions. One of the main
mechanisms that impart this repression is through direct recog-
nition of the methylated DNA by methyl binding proteins (MBPs),
which recruit HDACs to deacetlyate histones. It can also further
recruit other enzymes such as the H3K9 histone methyltransfer-
ase Suvar39h, which can lead to further repression by recruiting
HP1 and spreading the repressive state (Cheutin et al., 2003;
Schotta et al., 2004), as well as the recruitment of DNMT1, which
can further methylate adjacent DNA and lead to heterochroma-
tization and more robust silencing of the region (Smallwood
et al., 2007). This mechanism is known to occur in X chromo-
some inactivation (Sado et al., 2000) (Figure 3A). However, one
of the most striking examples for the requirement to properly
read the methylation mark is the autism spectrum disorder
Rett syndrome, in which mutations in a DNA methylation
‘‘reader,’’ MeCP2, causes widespread defects in neuronal matu-
ration, leading to deficiencies in learning, behavior, and seizures,
and it is an example of a protein linking epigenetic and neuronal
function (Guy et al., 2011; Moretti and Zoghbi, 2006). Alterna-
tively, specific mutations in MeCP2 have been suggested to
impair its ability to bind 5-hmC rather than 5-mC in the brain,
leading to reduced transcriptional activity (Melle´n et al., 2012).
Another example is in the case of imprinting, when one of the
parental alleles must be silenced via a methylation mechanism
in order to allow normal development. Aberrant imprinting of
specific regions can cause severe mental retardation and
autism, such as in Angelman syndrome and Prader-Willi syn-
drome, in which the imprinting control regions fail to be methyl-
ated, leading to aberrant expression and disease (Barlow, 2011;
Chamberlain and Lalande, 2010).
Methylation of transcription factor binding sites is another
mechanism whereby the transcriptional response of cells can
be epigenetically regulated by methylation. For example,
CTCF, a factor known to function in transcriptional repression,
insulator function, and chromatin looping, fails to bind to its
binding site when it is methylated, initially shown on the H19/
Igf2 imprinting control region (Bell and Felsenfeld, 2000; Hark
et al., 2000). More recently, the ENCODE effort estimated that
40% of variable CTCF binding is linked to differential methyla-
tion, mainly at two critical positions within the CTCF binding
motif (Wang et al., 2012). Other examples include AP-2, which
plays a critical role in regulating gene expression during early
development (Comb and Goodman, 1990), and YY1, a protein
that is involved in repressing and activating a diverse number
of promoters (Kim et al., 2003; Tate and Bird, 1993). It may be
possible that in addition to chromatin structure, methylation of
transcription factor binding sites is a general mechanism by
which cells epigenetically regulate which site will be ‘‘acces-
sible’’ for binding at a given time and cell type, from the myriad
of potential binding sites available in the genome (Choy et al.,
2010). This raises the possibility that modulating the methylation
landscape in a cell can contribute to modulating the pattern of
transcription factor binding at a genome-wide scale. Conversely,
it is also possible that the ability to methylate a transcription
factor binding site might be dependent on the occupancy of
that site by the specific factor, since it has been suggestedthat in cancer a major factor determining the ability to de novo
methylate specific sequence motifs at CpG islands is the
absence of the cognate transcription factor (Gebhard et al.,
2010). More recently, the ENCODE Project compared methyla-
tion across 19 cell types using RRBS for which DNase I hyper-
sensitivity data was also available, a measure of chromatin
accessibility mostly due to regulatory factor binding (Neph
et al., 2012; Thurman et al., 2012). Of35,000DNase I hypersen-
sitivity sites that contained CpGs, 20% showed significant asso-
ciation between methylation and accessibility, predominantly
indicating that increased methylation was negatively associated
with accessibility. These analyses highlight the advantage of
obtaining a genome-wide methylation map at single base pair
resolution by restricting the potential cohort of regulating tran-
scription factors of a given gene by suggesting those that have
available (nonmethylated) binding sites.
Taken together, although methylation has been studied exten-
sively for many years, new sequencing-based methodologies
are facilitating new and exciting discoveries that are helping to
redefine our understanding of the functions of this important
epigenetic modification.
Epigenomic and Transcriptomic Signatures of Brain
Plasticity
Accumulating lines of evidence have shown that crucial players
of synaptic plasticity function as epigenetic regulators and that
mutations and variations in their genes are linked to mental
illnesses. Therefore, epigenomic and transcriptomic profiles
may serve as signatures of physiological states and pathological
stages. Different experimental approaches have been used
to correlate neural plasticity with epigenetic control of gene
expression. Indeed, activity-dependent gene expression re-
sponses (West and Greenberg, 2011), along with changes in
posttranslational modifications of histone tails such as acetyla-
tion, phosphorylation, and methylation, have been observed in
hippocampus-dependent memory formation in rodents (Bredy
et al., 2007; Chwang et al., 2006; Fischer et al., 2007; Gupta
et al., 2010). Taking advantage of ChIP-seq, Peleg and
colleagues mapped the genome-wide pattern of acetylated
histone marks in aging brain and showed that, surprisingly,
H4K12Ac levels on gene bodies of ‘‘learning-associated genes’’
rose during associative learning, thus suggesting an epigenetic
control of transcriptional elongation during memory formation
(Peleg et al., 2010). Moreover, the authors demonstrated that
Fmn2, a gene that encodes an actin regulatory protein and is
required for normal memory formation, exhibits impaired tran-
scription in aged mice together with reduced H4K12 acetylation,
supporting the hypothesis that dysregulation of epigenetic
mechanisms can be causally involved in cognitive decline.
Cognitive functions have also been correlated with the activity
of histone-modifying enzymes. One of the best examples is the
histone acetyltransferase CBP, a protein encoded by a gene
mutated in the Rubinstein-Taybi neurodevelopmental syndrome
characterized by mental retardation (Petrij et al., 1995). Genetic
mutations of the Cbp gene in mice impair memory formation
and long-term potentiation (Alarco´n et al., 2004). Similarly,
HDACs are involved in the regulation of cognition. For example,
overexpression of the Hdac2 gene in the hippocampus of mice
negatively regulates synaptic plasticity and memory formationNeuron 77, February 20, 2013 ª2013 Elsevier Inc. 613
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tected in mouse models of neurodegeneration, as well as in
Alzheimer’s disease patients, along with repression of genes
implicated in learning and memory (Gra¨ff et al., 2012). In fact,
pharmacological interventions that regulate epigenetic mecha-
nisms in neurons, such as HDAC inhibitors, promote long-term
potentiation, lead to the reactivation of learning-induced gene
expression in the aging brain, and restore learning ability in
mice exhibiting severe neurodegeneration (Fischer et al., 2007;
Levenson et al., 2004; Peleg et al., 2010).
Histone methylation is also emerging as a central mechanism
underlying cognitive functions. For example, genetic ablation of
the histone H3K4 methyltransferase MLL1 interferes with con-
solidation of contextual fear memories (Gupta et al., 2010); and
the postnatal neuron-specific deletion of the histone methyl-
transferase G9a/GPL in mice elicits cognitive and behavioral
defects through deregulation of H3K9 methylation (Schaefer
et al., 2009).
While mutations in genes encoding epigenetic regulators can
be directly associated with distinct congenital disorders, psychi-
atric disorders are etiologically complex diseases involving both
genetic predisposition and environmental factors. The lack of
straightforward genetic causes together with the observation
of long-lasting gene expression changes in many affected indi-
viduals (Balu and Coyle, 2011) have prompted the hypothesis
that epigenetic mechanisms may act as a ‘‘bridge’’ connecting
the gap between genetic risk factors linked to major psychoses
and autism (copy number variation, polymorphisms) and envi-
ronmental events, such as stress, diet, drug exposure, and social
behavior (Feil and Fraga, 2011). In fact, differences in both DNA
methylation and histone marks have been observed in studies of
postmortem human brain of individuals suffering these various
diseases (Dempster et al., 2011; Mill et al., 2008). Moreover,
genetic studies in mice implicate histone-modifying enzymes
in the regulation of affective behaviors, including the H3K9
methyltransferases SETDB1 (Jiang et al., 2010) and G9a/GLP
(Schaefer et al., 2009) and the H3K4 methyltransferase SMCX
(Tahiliani et al., 2007).
Taken together, these and other studies support the hypoth-
esis that a fine-tuned regulation of chromatin signatures acts
as amolecular mechanism tightly associated with neuronal plas-
ticity and environmental adaptation. The challenge nowwill be to
expand these studies with genome-wide approaches that may
identify new association between the epigenome and behavioral
traits in normal and diseased brain.
The Regulatory Functions of ncRNAs in the Epigenetic
Control of Transcription
As previously mentioned, transcriptomic data generated by
high-throughput sequencing methods have established that
most of the genome is transcribed. However, the majority of ex-
pressed transcripts do not derive from coding genes but from
small and long noncoding genes or genomic sequences without
apparently protein-coding potential. Intriguingly, many of these
noncoding transcripts are far more than just transcriptional
‘‘noise’’ (Wang and Chang, 2011). Different sequencing-based
assays have been developed to profile RNAs (Table 1). Further-
more, genome-wide profiling of histone marks that are indicative
of promoters or gene bodies also provides an unbiased strategy614 Neuron 77, February 20, 2013 ª2013 Elsevier Inc.to identify ncRNAs. These assays have revealed an unexpected
anatomy of genome organization, whereby ncRNAs can be tran-
scribed from overlapping coding sequences, intergenic loci, or
highly specialized chromosomal regions (e.g., telomeres and
centromeres) in both sense and antisense or bidirectional orien-
tations (Figure 4A). Different sequencing-based assays to profile
RNA molecules on a genome-wide scale have been developed
(Table 1). Small ncRNAs, including snoRNAs, miRNAs, piRNAs,
siRNAs, and Alu-derived RNAs, are highly conserved and gener-
ally mediate gene silencing regulating mRNA stability and trans-
lation in a posttranscriptional manner (Holley and Topkara,
2011). Long ncRNAs, in contrast, do not show a high degree of
sequence conservation and engage in a broad range of biolog-
ical pathways acting as direct regulators of gene expression
(Wang and Chang, 2011) (Figure 4B). Indeed, long ncRNAs can
serve as molecular signatures of specific spatiotemporal, devel-
opmental, and signal-specific events, as in the case of XIST,
an ncRNA whose expression marks active silencing during X
chromosomal inactivation (Zhao et al., 2008). Long ncRNAs
can also function as ‘‘guides’’ to dictate chromatin states by tar-
geting histone-modifying activities to specific loci either in cis or
in trans, such as HOTAIR, which recruits Polycomb complex 2
(PRC2) and lysine demethylase LSD1 to specific genomic loci
(Rinn et al., 2007; Tsai et al., 2010). Long ncRNAs can act in trans
as molecular decoys sequestering specific DNA binding
proteins, such asGas5, which inhibits the action of the glucocor-
ticoid receptor (GR) (Kino et al., 2010). LncRNAs can also guide
transcription factors, as in the case of the ncRNA SRA that coac-
tivates nuclear receptors, including estrogen receptor (ERa), as
part of a ribonucleoprotein complex (Cooper et al., 2011; Lanz
et al., 1999). Additionally, lncRNAs can mediate short- and
long-range chromosomal interactions by connecting enhancer
and promoter regions, thus functioning as enhancer-like
elements despite being RNAs (Ørom et al., 2010). Finally,
lncRNAs can function as scaffold molecules to assemble subnu-
clear structures, such asMALAT1 and TUG1 (Yang et al., 2011).
Therefore, some ncRNAs can be considered as functional
molecular regulators comparable to proteins and are likely to
combine different mechanisms to achieve a specific biological
function.
ncRNAs as Regulators of Neuronal Function and Their
Link to Disease
Increasing evidence has revealed the role of ncRNAs in regu-
lating neural gene expression programs across the lifespan
(McNeill and Van Vactor, 2012; Qureshi and Mehler, 2012).
Many ncRNAs, especially miRNAs and lncRNAs, are highly
enriched in the CNS and show precise temporal and spatial
expression patterns in different developmental stages, brain
regions, cell types, and subcellular localizations (Belgard et al.,
2011; Kapsimali et al., 2007; Mercer et al., 2008). In particular,
there are examples of ncRNAs that mediate epigenetic mecha-
nisms in neural processes. For example, Rajasethupathy and
colleagues, using a small RNA-seq approach, demonstrated
that piRNA levels are regulated during serotonin-induced long-
term facilitation in the Aplysia CNS and modulate this synaptic
plasticity event by inducing CpG methylation and silencing
the expression of a key plasticity-related gene, CREB2 (Rajase-
thupathy et al., 2012). Another class of small ncRNAs, derived
Figure 4. ncRNAs Function in the Brain
(A) Schematic illustration of various classes of RNA species derived by different genomic locations, including coding, short and long noncoding RNAs. Often
lncRNAs are defined based on their location relative to the coding gene as divergent, antisense, intronic, and bidirectional. Intergenic lncRNAs are transcribed by
separate transcriptional units.
(B) lncRNA mechanisms of action: ‘‘guide’’ histone-modifying enzymes to chromatin (XIST), scaffold molecules that bring together proteins complexes with
different enzymatic activities (HOTAIR), ‘‘looping’’ of distant genomic regions through the recruitment of protein complexes (enhancer-like RNAs), inhibition of
transcription factors binding to their cognate DNA motifs (GAS5), transcriptional activation by interacting with TFs, nucleation of nuclear structures (MALAT1), or
‘‘guide’’ of specific histone mark readers in distinct nuclear structures (TUG1).
(C) Model of RA-induced transcription of riRNAs in stem cells, where they target various mRNAs in an AGO3-dependent mechanism.
(D) Many lncRNAs have been linked to various neurological disorders, but their mechanism of action remains elusive.
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Reviewfrom Alu repeat elements, has been identified as the cause of a
degenerative condition (Kanekoet al., 2011). Indeed, adeficiency
in the miRNA regulator DICER1, which is observed in human
patients affected by macular degeneration, is responsible for
the accumulation of Alu transcripts in mice and, therefore, for
their cytotoxic effect mediated by inflammatory responses
(Tarallo et al., 2012). Alu-derived transcripts have also been
associated with stem cell maintenance during retinoic acid
(RA)-induced differentiation (Hu et al., 2012). Indeed, using bio-
informatic analyses, it was found that 10% of Alu repeats in
the human genome harbor nuclear receptor binding sites (Polak
and Domany, 2006), including retinoic acid receptor (RAR). Hu
and colleagues show that in ESCs, retinoic acid induces the
transcription of DR2-Alu elements leading to the AGO3-depen-
dent generation of a new type of RA-induced small RNA (riRNA),
which causes the degradation of mRNAs necessary to maintain
the stem cell-proliferative state that might be crucial in neuronal
differentiation. Whether Alu-derived transcripts induced by
ligand-dependent nuclear receptors have a function in the brain
will be a fascinating question to address (Figure 4C).
Several reports have raised provocative questions on the
function of another class of repetitive elements, the retrotrans-
posable elements LINE-1 (L1), which have been proposed to
contribute to somatic mosaicism in the brain (Singer et al.,
2010). These studies provide evidence of active retrotransposi-
tion of L1 during brain development and adult neurogenesis
(Coufal et al., 2009; Muotri et al., 2005, 2009). Subsequent
studies also implicate the activity of L1 elements in brain disor-
ders; particularly, Rett syndrome-associated mutations have
been shown to elevate the rate of transposition both in mice
models of RTT and patient-specific induced pluripotent
stem cells (iPSCs) (Muotri et al., 2010). However, there is still
controversy regarding the contribution of this mechanism to
the brain’s genetic heterogeneity. Indeed, a recent finding,
based on the amplification of single neuronal genomes from
human brain, failed to detect significant somatic insertions by
deep sequencing (Evrony et al., 2012).
Finally, different lncRNAs have been implicated in regulatory
mechanisms of gene expression via different mechanisms in
neurons. For example, RNA-seq analysis in cultured neurons
showed that the expression of activity-dependent genes is
correlated to bidirectional transcription of eRNAs, which are
derived by nearby enhancer elements marked by H3K4Me1
and by the activity-induced binding of CBP and RNAPII, as de-
tected by ChIP-seq (Kim et al., 2010). Whether eRNAs have
a functional role in neuronal transcriptional regulation or estab-
lishment of neuronal chromatin states is yet to be determined.
However, a recent report suggested a functional role for these
ncRNAs in transcriptional regulation, showing that eRNAs, which
are transcribed from enhancer elements bound by the transcrip-
tion factor p53, are able to enhance transcription of neighboring
p53 target genes in an RNA-tethering reporter assay or by
suppressing them via siRNAs (Melo et al., 2012). In this regard,
the application of GRO-seq methodology might be of great
value to profile signal-dependent transcription of eRNAs (Core
et al., 2008; Wang et al., 2011).
Many lncRNAs have also been identified from loci associated
with neurological and neurodegenerative disorders; however,616 Neuron 77, February 20, 2013 ª2013 Elsevier Inc.their function remains elusive in most cases (Figure 4D), for
example, lncRNA SCAANT1 derived from a triplet repeat expan-
sion locus mutated in the spinocerebellar ataxia type 7 (Sopher
et al., 2011); lncRNAs transcribed from the FMR1 locus associ-
ated to fragile X syndrome (Khalil et al., 2008); UBEA3-AS
transcript linked to the Angelman syndrome (Lalande and Cal-
ciano, 2007); lncRNAs involved in neurodegenerative diseases,
such as REST-dependent lncRNAs in Huntington disease (John-
son et al., 2009) or BACE-AS and 17A lncRNAs in Alzheimer’s
disease (Faghihi et al., 2008; Massone et al., 2011); and DISC2
associated with psychiatric disorders (Chubb et al., 2008).
The advent of deep sequencing methods has also provided an
unprecedented tool to uncover novel functions of RNA-protein
and RNA-DNA interactions. In respect to RNA-protein interac-
tions, CLIP-seq and PAR-CLIP, which are two similar deep
sequencing approaches, have been developed to profile the
association of RNA binding proteins to the transcriptome (Table
1). Particularly in neurons, CLIP-seq of Nova, a neuron-specific
splicing factor that is targeted by autoantibodies in brain tumors,
led to the discovery that Nova regulates alternative polyadenyla-
tion of transcripts in the brain (Licatalosi et al., 2008; Zhang et al.,
2010). Similarly, CLIP-seq of FMRP, a protein encoded by a gene
mutated in fragile X syndrome, uncovered a new function for
FMRP as a translational repressor capable of stalling ribosomal
translocation (Darnell et al., 2011).
In respect to RNA-DNA interactions, the genome-wide binding
profile ofHOTAIR by ChIRP-seq, which is a method to profile the
association of RNA molecules to the genome, revealed the
important role of this lncRNA in silencing gene transcription by
nucleating Polycomb complexes at specific genomic loci and
facilitating the formation of repressive H3K27me3 regions
(Chu et al., 2011). Given the abundance of lncRNAs in the brain
and their known link to various neuronal functions, the applica-
tion of this assay may be of particular value in the field of
neurobiology.
Finally, another general theme emerging from multiple func-
tional analyses of ncRNAs is their tendency to nucleate the
assembly of multisubunit ribonucleoprotein complexes. For
example, the lncRNA MALAT1, which is functionally essential
for structural integrity of nuclear paraspeckles, controls synapse
formation through regulating gene expression and alternative
splicing in hippocampal neurons (Bernard et al., 2010). Interest-
ingly, the lncRNAsMALAT1 and TUG1 are capable of guiding the
relocation of signaling-induced genes from the silencing environ-
ment of Polycomb bodies to the transcriptionally active subnu-
clear compartment of interchromatin granules (Yang et al.,
2011). It would be interesting to test whether neuronal activity
could induce such a relocation strategy to regulate gene expres-
sion. It is not surprising, therefore, that alterations in nuclear
organization have recently been linked to CNS diseases, such
as laminopathies (Maraldi et al., 2011) and cohesinopathies
(Liu and Krantz, 2009), or neurodegenerative disorders charac-
terized by nuclear inclusions (Casafont et al., 2009). Indeed, it
is now evident that gene regulation involves a complex genomic
architecture organized in functional nuclear territories (Caudron-
Herger and Rippe, 2012; Mao et al., 2011). Deep sequencing
assays to profile the organization of the genome in the nuclear
space could shed light on the underlying molecular mechanisms
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the network of chromosomal interactions induced by neuronal
activity involving distant functional elements, such as CBP-regu-
lated enhancers and promoters.
The Value of the Epigenome in the Field of In Vitro-
Generated Neurons
In vitro-generated neurons are emerging as a valuable tool to
study multiple aspects of neuronal function and disease. The
classic approach to derive human neurons in vitro involves the
differentiation of ESCs into NPCs and then into neurons (Peljto
and Wichterle, 2011). More recently, however, somatic cells
have also been reprogrammed into pluripotent stem cells, or
iPSCs (Takahashi and Yamanaka, 2006; Yu et al., 2007), and
then differentiated into neurons (Brennand et al., 2011; Cham-
berlain et al., 2010; Ebert et al., 2009; Israel et al., 2012; Karum-
bayaram et al., 2009; Marchetto et al., 2010; Park et al., 2008;
Pasxca et al., 2011). Somatic cells can also be directly converted
(or transdifferentiated) into NPC and/or neurons via transduction
of neural-specific transcription factors and/or ncRNAs, or more
recently via repression of a single RNA binding polypyrimidine
tract binding (PTB) protein (Ambasudhan et al., 2011; Caiazzo
et al., 2011; Lujan et al., 2012; Pang et al., 2011; Pfisterer
et al., 2011; Qiang et al., 2011; Ring et al., 2012; Son et al.,
2011; Vierbuchen et al., 2010; Xue et al., 2013; Yoo et al.,
2011). These new strategies have garnered extraordinary atten-
tion since they uniquely allow generation of neurons from
patient-derived cells, which is expected to be particularly valu-
able in the study of neuronal disease, the development of
personalized therapies, and regenerative medicine in the future
(Abdullah et al., 2012; Ronaghi et al., 2010; Young andGoldstein,
2012). We will not discuss these interesting aspects here
since they fall beyond the scope of this Review. Instead, we
propose to highlight how the use of new sequencing methodol-
ogies could help to assess a pertinent long-standing question in
the neurobiology field; in particular, what defines the identity of
a neuron and how does that relate to the vast neuronal diversity
observed in the brain? In fact, the possibility of generating
neurons by these different approaches, especially considering
the multiple experimental protocols that have been reported,
raises the intriguing technical question of whether all these vari-
ants are equivalent in generating similar types of cells. Arguably,
this question needs to be addressed in order to determine to
what extent in vitro-generated neurons can mimic the rich
repertoire of neuronal diversity that exists in the brain. Since
epigenetic regulators (writers, erasers, and readers) are key in
‘‘erasing’’ somatic epigenetic features and then ‘‘rewriting’’
new ones that define the reprogrammed state, we propose
that a comprehensive and systematic analysis of the epigenome
of in vitro-derived neurons and a direct comparison with the
epigenome of endogenous neurons of the different regions of
the brain can be instrumental in answering such questions,
perhaps also contributing to harnessing the full clinical potential
of these cells.
Using ‘‘Epigenomic Barcodes’’ to Define Neuronal
Identity
The challenge of generating a ‘‘neuron’’ does not end when re-
programmed cells show expected neuronal properties, since (1)they should not concurrently show nonneuronal features and (2)
they should not simultaneously show features of different
neuronal subtypes. In fact, there are substantial physiological
and morphological variations among neurons from different
regions in the brain (Urban and Tripathy, 2012), which need to
be accounted for when defining a neuron in vitro. We can
certainly trace specific ‘‘biomarkers’’ and their neuronal func-
tions to establish the identity of a neuron, but such an approach
might not be sufficiently comprehensive in considering the
complexity of these cells and the mechanisms employed to
generate them in vitro. Instead, genome-wide transcriptome
and epigenome profiles may provide a more global assessment
of the level of neuronal differentiation, transdifferentiation, or
reprogramming. Transcriptomic profiles of steady-state mRNA
(measured by either microarray or RNA-seq) have already
been shown as highly valuable for identifying neuronal subtypes
(Hawrylycz et al., 2012), and in the future even more if com-
plemented with profiles of RNA undergoing transcription
(measured by GRO-seq) and translation (measured by Ribo-
seq) (Table 1 and Figure 1). In fact, RNA profiles undergoing
translation have already been exploited in the identification of
region-specific neuronal signatures, which is exemplified by
an ongoing collaborative effort at the Rockefeller University
for the development of the translating ribosome affinity purifica-
tion (TRAP) methodology, which is an elegant genetic approach
that enables the expression of an EGFP-tagged ribosomal
protein in a particular cell population of the mouse brain and,
therefore, the isolation of polyribosomes and the profiling of
associated mRNAs only from the cell population of interest
(Doyle et al., 2008; Heiman et al., 2008). Such a strategy has
the potential to overcome the technical limitations associated
with isolating and characterizing region-specific neurons within
the large complexity of cell types in the brain. However, tran-
scriptome profiles may fail to provide key identity information
that is only harbored by the epigenome, such as some cell
fate features (Garrison et al., 2007) and the depth of identity
resetting when neurons are generated in vitro. In this regard,
a recent comparison of iPSCs and the original somatic cells
revealed that the reprogrammed cells maintain epigenetic
features that are reminiscent of their origin or contain new
features that result from the reprogramming process itself
(Lister et al., 2009; Marro et al., 2011; Tian et al., 2011). The
epigenome may also provide information for neuronal identity
and diversity via enhancer profiles. For example, a recent profile
of enhancer-specific histone marks showed robust patterns
that were distinctive of cortex, cerebellum, olfactory bulb, and
E14.5 brain regions (Shen et al., 2012). Other studies have
similarly shown DNA methylation profiles distinctive of different
brain regions (Davies et al., 2012; Ladd-Acosta et al., 2007;
Maunakea et al., 2010). Therefore, histone marks and DNA
methylation patterns are valuable ‘‘barcodes’’ of neuronal
identity and diversity, which could be exploited to elucidate
similarities and differences between the epigenome of in vitro-
generated neurons and neuronal subtypes by the different
protocols available to generate these cells. With a parallel
comprehensive analysis of endogenous neurons from different
regions in the brain (as similarly done in the analysis of the
transcriptome), it may now be possible to determine whichNeuron 77, February 20, 2013 ª2013 Elsevier Inc. 617
Figure 5. The Epigenome to Assess Neuronal Identity of Reprogrammed Cells
(A) There are three common strategies to generate a neuron in vitro (differentiated from ESCs, iPSCs, or directly transdifferentiated from somatic cells), and each
might be accomplished by different protocol variants (represented as 1–4). However, it remains unclear how similar the level of conversion, efficiency, and
reproducibility is to the neural lineage between them, and which is the most similar to endogenous neurons (center of the image). Since transcriptomes may miss
some identity features that epigenomes reveal, we propose a systematic use of the second as potential ‘‘barcodes’’ to establish the most appropriated protocol.
(B) Neurons exhibit an especially high identity diversity or heterogeneity; therefore, systematic epigenetic profilingmight be a useful tool to catalog and distinguish
between these different identities. Furthermore, such catalogs may facilitate the search and identification of the best protocols to generate these different
identities in vitro (bottom).
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its endogenous counterpart (Figure 5). Obviously, these aspects
represent enormous challenges since it is unclear to what
extent all neuronal subtypes have been identified and if current
experimental approaches can efficiently and unambiguously
isolate these subtypes.
In summary, the profiling of the epigenome might provide
a more comprehensive profile of the identity of an in vitro-gener-
ated neuron compared to the assessment of a limited number of
neuronal traits. It may also help to establish which protocol
derives neurons with the best fidelity to endogenous neuronal
subtypes and whichminimizes the residual effects of the conver-
sion process. If performed systematically and comprehensively,
these analyses may likely facilitate our future understanding of
the neuron and facilitate the application of in vitro-generated
cells in both the basic science and clinical arenas, perhaps
minimizing potential future controversies caused by use of differ-
ential methodologies andmitigating risks when applied to poten-
tial therapies.
Challenges in the Future of Deep Sequencing
Recent advances in high-throughput sequencing approaches,
particularly when combined with analyses of epigenetic618 Neuron 77, February 20, 2013 ª2013 Elsevier Inc.processes, have now allowed us to (1) classify and/or ascribe
potential regulatory functions to vast sections of the genome,
many of which were previously considered ‘‘junk’’; (2) uncover
the considerable cell-type specificity of enhancer profiles and
the predominance of these elements over promoters as the
drivers of cell identity; (3) consider a redefinition of what consti-
tutes a functional gene unit and its various regulatory regions,
since many enhancers and even promoters generate RNAs
and interact in the three-dimensional nuclear space for proper
coordination of gene expression; (4) identify a multitude of new
ncRNAs in addition to the protein-coding transcripts; and (5)
particularly in neurons, to identify the importance of epigenomic
mechanisms in neuronal function, identity, diversity, in vitro
generation, and disease.
The avalanche of new data that has accompanied these new
discoveries has also raised some important questions. What is
the conceptual difference between a promoter and an enhancer,
since both regions bind transcriptional regulatory proteins and
generate RNA transcripts? How can gene promoters be as-
signed to their respective regulating enhancers? What are the
rules governing the promoter-enhancer interactions as well as
interactions between other distal regulatory elements? Exactly
how and to what extent does the three-dimensional organization
Neuron
Reviewof the nucleus exert a regulatory function on gene expression?
How long are the dynamic epigenetic changes, induced by
brain activity, maintained or propagated? To what extent are
they required for proper neuronal function? What is the variation
in these changes when probed at the level of single neurons
and are such differences based on stochastic or predefined
mechanisms? In this respect, new developments in single-cell
sequencing methodologies have already allowed us to amplify
genomes of single neurons to assess the genomic diversity of
human brains (Evrony et al., 2012).
While the value of current and developing deep sequencing-
based approaches is undeniable, there are still substantial
technical and analytical challenges associated with their appli-
cation (Kircher and Kelso, 2010). For example, differences in
reagents and sequencing platforms can lead to certain biases
that may give rise to differential results and complicate compar-
isons between separate studies. There is also the significant
computational challenge of uniformly analyzing and effectively
sharing deep sequencing data and the financial burden for scien-
tific programs worldwide that is associated with the massive
production and maintenance of these data sets. However, argu-
ably the biggest challenge of all is how to effectively mine the
vast information derived from deep sequencing data. Computa-
tional and systems biology scientists clearly must play a major
role in the discovery process, devising computational tools and
increasing the accessibility to sequencing-based data. The
continuing discovery of additional histone and DNA modifica-
tions and their respective distributions in the genome, and the
continuing ingenious application of sequencing technologies to
biological questions, will undoubtedly provide fertile ground for
further research into their function.
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